Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 26-year-old man comes to the clinic for treatment of a painless penile chancre. Darkfield microscopy confirms the presence of Treponema pallidum, and his baseline rapid plasma reagin (RPR) titer is 1:64. He is administered a single dose of intramuscular benzathine penicillin G for primary syphilis. He is otherwise healthy, has no allergies, and tests negative for HIV. The patient asks the physician how they will know if the infection has been successfully cured. Which of the following statements represent the appropriate monitoring and evaluation plan for this patient? (Select all that apply)

  1. Repeat non-treponemal titer testing at 6 and 12 months after treatment.Cevap
  2. Confirmation of at least a four-fold decrease in the non-treponemal titer.Cevap
  3. C
    Repeat treponemal-specific antibody testing (e.g., TP-PA) at 12 months.
  4. D
    Repeat non-treponemal titer testing 4 weeks after treatment to confirm immediate response.
  5. E
    Confirmation of a completely nonreactive (negative) non-treponemal titer by 6 months.

Cevap

The appropriate monitoring plan involves repeating the non-treponemal titer (RPR) at 6 and 12 months and confirming at least a four-fold decrease in the titer.
The correct answers identify that non-treponemal tests (such as RPR or VDRL) should be repeated at 6 and 12 months, and that a four-fold decrease in titer (e.g., from 1:64 to 1:16, representing two dilutions) is considered an adequate therapeutic response. Non-treponemal titers reflect current disease activity and decline gradually following successful treatment.

Adım Adım Çözüm

1
Identify the patient's diagnosis and baseline laboratory status.
The patient has primary syphilis with a baseline RPR titer of 1:64.
Establishing the baseline titer is necessary because treatment success is evaluated relative to this initial quantitative value.
2
Select the appropriate laboratory test for longitudinal monitoring.
Non-treponemal tests (RPR or VDRL) are selected over treponemal tests (TP-PA, FTA-ABS).
Non-treponemal antibody levels correlate with active disease and decline after successful treatment, whereas treponemal antibodies typically remain positive for life.
3
Determine the correct monitoring intervals and criteria for cure.
Testing should be performed at 6 and 12 months to look for at least a four-fold decrease in the RPR titer (e.g., a drop from 1:64 to 1:16 or lower).
Antibody titers decline slowly. A four-fold drop by 6 to 12 months confirms adequate treatment response, even if the titer does not become entirely negative.

Anahtar Kavram

Monitoring and Treatment Evaluation for Primary Syphilis
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru